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by Linda Oglesby,* Cathy Hix-Baker,t# Pat MacNair,*
Marianne Sieg,* Linda Snow* and Robert Langenbacht§
A bovine bladder cell-mediated mutagenesis system using Chinese hamster V79 cells and Salmo-
nella typhimurium as target organisms was developed to investigate the capacity of the bladder
urothelium to activate chemical carcinogens. Bovine bladder epithelial cells can activate the aro-
matic amines AF and 4-ABP to intermediates which mutate V79 cells and S. typhimurium TA 98
and TA 100. DMBA was mutagenic to V79 cells but not detectably mutagenic to either Salmonella
strain with bladder cell activation. The chemicals tested were not mutagenic to either target or-
ganism in the absence of bladder cells. In contrast to the response with DMBA, S. typhimurium was
a more sensitive target for the arylamines than V79 cells. These data suggest the value of using
multiple end points for assessing metabolic capability. The activation capability of intact bladder
cells was compared to disrupted cells, and S-9 prepared from bladder cells used with and without
cofactors. When intact cells or S-9 plus cofactors were used as the activation system a dose-
dependent increase in revertants was observed for 4-ABP. A bovine liver cell-mediated bacterial
mutagenesis system was also developed and the liver and bladder systems compared. For AF,
bladder cells appear to be at least ten times more active per viable cell than hepatocytes in
producing mutagenic intermediates, while 4-ABP is essentially not mutagenic in the hepatocyte-
mediated system. A quantitative comparison of the relative importance of the liver and bladder to
activate the chemicals is difficult to make but the data indicate the ability of the bladder epithelium
to activate bladder carcinogens.
Introduction
The role of specific chemicals associated with hu-
man neoplasms was first observed with arylamine-
induced bladder cancer in workers associated with
chemical dye and rubber industries (1-5). Many sub-
sequent studies have shown that aromatic amines
are carcinogenic in experimental animals and that
species differences in the incidence of tumors exist.
It is known that procarcinogens such as aromatic
amines require metabolic activation to manifest
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their biological effects (6, 7). For the initiation of
bladder cancer by aromatic amines two major theo-
ries concerning the organ site of activation have
emerged. One theory relies on metabolic activation
and conjugation occurring in the liver and the conju-
gated amine reaching the bladder via the urine (8,
9). The reactive intermediate which can interact
with cellular constituents of the bladder epithelium
is generated by hydrolysis of the conjugate in the
urine. This hypothesis assumes a somewhat passive
role for the bladder epithelium in carcinogen ac-
tivation. An alternate theory on bladder tumor
initiation is that metabolic activation of a carcino-
gen, or its metabolite, to ultimate reactive form(s)
occurs enzymatically within the bladder epithelium
itself. Indeed, studies have indicated that the
bladder epithelium of several species, including
humans, can metabolize carcinogens (9-14). Until
recently little was known about the role of the
urothelium during bladder tumor induction. Rapid
absorption, metabolism, and re-excretion of aryl-
amines after direct instillation into the bladderOGLESBYETAL.
was observed by Oglesby et al. (15) and others (16-
18). These studies suggest that the parent chemical
and some metabolites are able to traverse the
luminal urothelial membrane and that the urotheli-
um is not as inert or impermeable to xenobiotics as
earlier believed. The two theories on liver or
bladder as sites of metabolic activation of bladder
carcinogens may not be mutually exclusive as both
organs may have significant roles with variables
such as species and sex as well as chemical class of
initiator being contributing factors.
We have been interested in developing in vitro
cellular mutagenesis systems as a model to study
the phenomenon of organ and species specificity of
chemical carcinogens (11, 12, 19-25). The approach of
cell-mediated mutagenesis was developed by Huber-
man and Sachs (26) and used Chinese hamster V79
cells as the mutable target and rodent embryonic fi-
broblasts as the activating cell. A hepatocyte-medi-
ated mutagenesis system was developed (19) to ex-
pand the spectrum of chemicals which could be
studied by this approach. Subsequently, rat fibro-
blast and rat hepatocyte activation of benzo(a)py-
rene and aflatoxin B1 were compared and a cell type
specificity in carcinogen activation was demon-
strated (20). We further extended this approach to
include lung, kidney and bladder cells for metabolic
activation which allowed an investigation of organ
specificities of carcinogen activation (22, 25). A cor-
relation between in vitro cell-mediated mutagenic
activity for nitrosamines and hydrocarbons with in
vivo carcinogenic activity for these classes of chemi-
cals has been shown (25).
The data in Table 1 summarize some results com-
paring the relative abilities of rat liver and bladder
cells to activate the carcinogens, dimethylnitrosa-
mine (DMN) and 7,12-dimethylbenz(a)anthracene
(DMBA) and the noncarcinogen, anthracene (12). As
can be seen in Table 1, rat bladder epithelial cells
can activate both of the carcinogens to mutagens, al-
though the level of induced mutagenesis with DMN
is less than with rat liver cell activation. DMBA is
Table 1. Relative mutagenic activities of DMBA and DMN
in the rate liver and bladder cell-mediated V79
mutagenesis system.
Conen. Activating cell typea
Chemical ,ug/mL Liver Bladder
Anthracene 3 1 1
DMBA 1 14 21
DMN 100 95 11
aData expressed as fold increases over background with
ouabain as the selective agent in the liver cell-mediated sys-
tem and 6-thioguanine as the selective agent in the bladder
cell-mediated system. The ouabain background (liver) was 1
and 6TG background (bladder) was 3 for all experiments. (12,
22).
activated about equally in cells from both organs.
These findings prompted us to investigate the acti-
vation of other chemical carcinogens by bladder epi-
thelium and, furthermore, because of low rat blad-
der epithelial cell yield to utilize a species which
would yield greater cell numbers. In the present re-
port, data are presented for two aromatic amines, 2-
aminofluorene (AF) and 4-aminobiphenyl (4ABP),
which show (1) bovine bladder epithelial cells can ac-
tivate aromatic amines to intermediates which mu-
tate V79 cells and/or Salmonella typhimurium, (2)
bovine bladder cells on a per cell basis give higher
levels of S. typhimurium mutagenesis than bovine
liver cells, and (3) bovine bladder urothelial cell S-9
can also activate AF and 4ABP to mutagens.
Materials and Methods
Carcinogen Preparation
Test chemicals were dissolved in dimethyl sulfox-
ide (DMSO) with solvent volume so adjusted that
the final concentration of DMSO did not exceed
0.2% in V79 culture and did not exceed 100,L per
petri plate in the Salmonella tests. DMBA was pur-
chased from Sigma Chemical Co. and AF and 4ABP
were purchased from Aldrich.
Bladder Cell Isolation
The isolation of bovine bladder cells is described
in detail elsewhere (27). Briefly, bovine bladders
were obtained from a commercial slaughterhouse
and kept on ice approximately 2 hr while being
transported to our laboratory. Each bladder was
filled with a trypsin-collagenase solution, suspended
in a 500 mL beaker and incubated for 20-22 hr at
4°C. The tissue was then warmed to 370C for 1 hr.
To harvest the urothelial cells the enzyme was
removed and the bladder lumen rinsed with sterile
HBSS. The bladder was slit down the side, laid flat
to expose the luminal surface and gently scraped
with a sterile spatula to collect the loosened cells.
The cell suspension was centrifuged at 300g for 5
min and resuspended in HBSS plus CaCl2 and
NaHCO3 (27) for Salmonella mutagenicity tests or in
complete medium (27) for V79 mutagenicity tests.
An average of 100 x 106 viable cells (by trypan blue
dye exclusion) per bladder was obtained.
Bladder Cell S-9 Mix Preparation
Ice cold bladder cell suspensions were sonicated
with a probe microtip sonifier (Cell Disrupter Model
350, Branson Sonic Power Co., Danbury, CT) on a
50% on-off cycle for the least time required to
break all cells, usually 20 to 30 sec (28). The broken
cell suspension was centrifuged at 9000g at 40C, for
20 min. The supernatant (S-9) was then mixed with
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cofactors as suggested by Ames et al. (29) to prepare
the S-9 mix. The S-9 equivalent of4 x 106 intact cells
(1.4 mg protein) was added to each plate. Protein was
determined by the method ofLowry et al. (30).
Hepatocyte Isolation
Bovine liver cells were isolated by a modification
(28) of the method of Fry et al. (31). Liver samples
were obtained within 10 min of death (from the
same slaughterhouse as bladders), were im-
mediately cut in 2-cm cubes and were placed in ice
cold PBS. About 3 g of 0.5 mm liver slices were
rinsed three times in PBS for 10 min at 370C in a
shaking water bath and then two times in PBS with
0.5 mM EGTA. Following the rinses, 10 ml of sterile
filtered collagenase-hyaluronidase solution was
added to the liver slices and incubated for 45 min at
370C. The partially digested tissue/cell suspension
was filtered through a. single layer of nylon screen
and the undigested slices were returned to the flask
and the collagenase-hyaluronidase digestion con-
tinued for three 30-min periods. Cells from the 30
min digestions were isolated, and their viability
ranged from 80 to 90%.
Salmonella Mutagenesis Assays
Figure 1 shows a diagram of the cell-mediated
bacterial system. The following were added to 2 ml
of 450C agar, 100 HL of a 16 hr nutrient broth cul-
ture of Salmonella typhimurium TA 100 or TA 98,
the chemical, and 900 ,uL of the bladder cells, hepa-
tocytes or S-9 mix. Two plates were prepared for
each treatment. Revertant colonies were counted
after 48 hr and background lawn of bacterial growth
confirmed. Both the bladder cells and hepatocytes
remained viable (by trypan blue dye exclusion) in the
agar during the twoday incubation.
V79 Cell Mutagenesis Assays
The V79 assay described by Langenbach et al.
(19) was used with some modification (see Fig. 2).
Bladder cells were added to 25 cm2 T-flasks that had
been seeded 18 hr earlier with V79 cells; two flasks
per treatment were used. After a 4-hr cell at-
tachment period, medium with floating cells was
gently removed and fresh medium containing the
chemical was added. Following a 48-hr chemical
treatment period, the cells were trypsinized and
counted on a hemacytometer. The first cloning
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FIGURE 1. Bovine bladder cell-mediated Salmonella typhimurium mutagenesis system experimental protocol.
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FIGURE 2. Bovine bladder cell-mediated V79 mutagenesis system experimental protocol.
Table 2. Bladder cells-mediated mutagenesis of V79 cells and Salmonella typhimurium.
Bacterial mutagenesis V79 mutagenesis
Concn, Cloning No.
mAg/ Revertants per platea Conen, efficiency 6-TGr mutants
Chemical plate TA100 TA98 ,g/mL O/ob /106 survivors
Control 112 18 Control 83 12
AF 10 1890 2083 5 64 170
20 2199 2382 10 50 217
4-ABP 10 911 148 10 68 87
20 1381 291 20 64 15
DMBA 10 173 41 1 57 176
aTo optimize mutagenesis, bacteria were incubated with the following number of bladder cells per plate: AF, 4ABP, DMBA 4
x 106.
bFirst cloning efficiency. To obtain optimum mutation frequencies. V79 cells were cocultivated with the following number of
bladder cells: AF, 8 x 106; 4ABP, 15 x 106; DMBA, 4 x 106. These values are from representative experiments which have been
repeated at least twice.
efficiency plates were seeded for a measure of
toxicity (eight dishes/point, 100 cells/plate). Two 75
cm2 T-flasks per treatment point were seeded with
3 x 105 V79 cells and allowed to grow for 4 days.
The cells were then reseeded for cloning efficiency
and 6-thioguanine resistance ( 2 x 104 cells/dish, 15
dishes/treatment point). The 6-thioguanine was
added 2 days later to a final concentration of 5
,ug/mL. The mutation frequency was calculated per
106 survivors based on the second cloning efficiency
and the number of cells seeded for mutant selection.
Results
Bladder-Cell Mediated Mutagenesis
The data in Table 2 show mutagenic activity of
the aromatic amines, AF and 4ABP, and the hydro-
carbon, DMBA, in the bladder cell-mediated S. typh-
imurium and V79 cell systems. DMBA is included
since it was previously shown to be positive in the
rat bladder-mediated V79 cell system (Table 1). AF
and 4ABP were mutagenic to TA 98 and TA 100
and to V79 cells with bovine bladder cell activation.
DMBA was mutagenic to V79 cells but not detect-
ably mutagenic to TA 98 and TA 100 with bovine
bladder cell activation. None of the chemicals were
mutagenic to either target organism in the absence
of bladder cell activation. The number of bladder
cells to give optimum mutagenic response for each
chemical has been determined and were used to ob-
tain the data in Table 2 (27). For the S. typhimurium
system, the optimum cell numbers were the same
for AF and 4ABP while DMBA was negative at
bladder cell numbers up to 10 x 10 per plate. How-
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ever, in the V79 system different bovine bladder
cell numbers were optimal for each chemical. Linear
dose responses at the optimum cell number ranged
up to 10 and 20 ,Mg/plate for AF and 4ABP, respec-
tively, before toxic effects were observed in the S.
typhimurium system (data not shown). Dose re-
sponses for AF in the V79 system were linear up to
20 ,ug/mL while for 4ABP, 10 ,Ag/mL gave maximal
mutagenic activity; with 5,ug/mL (data not shown)
and 20 pg/mL the mutagenic response was lower.
This may be due to a narrow dose-response range,
although high toxicity was not observed in ranges
where mutation decreased (Table 2). At higher
doses, toxicity of the chemicals or metabolites to
the bladder cells themselves may be the cause of de-
creased mutagenic activity. This complicated dose-
response phenomena for 4ABP in V79 cells and
greater sensitivity (fold increase over background)
for both AF and 4ABP with the bacterial system
caused us to use S. typhimurium as the target in
the remaining studies with AF and 4ABP.
Hepatocyte and Bladder Cell Activation of
Aromatic Amines
The relative abilities of bovine hepatocytes and
bovine bladder cells to produce mutagenic interme-
diates from AF and 4ABP are shown in Table 3.
The data have been expressed as revertants (minus
background) per 6 x 10 viable activating cells to fa-
cilitate a comparison of the two cell types (28). For
AF, the bladder cells appear to be at least ten times
more active on a per cell basis than hepatocytes in
producing mutagenic intermediates. While 4ABP
was essentially not mutagenic in the hepatocyte-me-
diated system, it was mutagenic with bladder cell
activation.
Comparison of Intact Bladder Cells and
Bladder Cell S-9 Activation
The aromatic amines, 4ABP and AF have been
studied for mutagenic activity to TA 98 with dis-
rupted bladder cells or with the bladder cell S-9
equivalent with and without cofactors (Fig. 3). In
these studies bladder cells and bladder S-9 were
prepared from the same animal to eliminate inter-
animal variation which can be as much as 10-fold
(27). For 4ABP, both intact cells and S-9 show a dose
dependent increase in revertants, but the
mutagenic activity in the bladder S-9 was about
three times greater at all doses than intact cells
(Fig. 3.). However, if the bladder cells are disrupted
and the homogenate without cofactors is used, the
mutagenic activity remains at the background level.
This indicates that leakage of enzymes is not
responsible for the mutagenic activity observed
with the intact cell system. Similar data are also
shown for AF with intact cells and S-9 activation.
However, for AF, bladder S-9 activation showed
only a slight increase over the response with intact
cells. As with 4ABP, incubation of AF with
sonicated bladder cells without addition of cofactors,
causes no increase in reverants per plate (data not
shown).
Discussion
The results reported herein combined with other
studies (11, 12, 27, 28) demonstrate that the blad-
der epithelium can metabolically activate several
classes of chemical carcinogens, including aromatic
amines, hydrocarbons, and nitrosoamines, to inter-
mediates which mutate V79 cells and/or S. typhimu-
rium. Uehlke (32) first demonstrated N-oxidization
of aromatic amines by bladder epithelium from sev-
eral species. However, Brill (33) using dog bladder
Table 3. Bovine hepatocyte and bladder cell activation of
aromatic amines to mutagens in Salmonella typhimurium.a
Concn, TA 98 revertants per plateb
m*g/ Hepatocyte- Bladder cell-
Chemical plate mediated mediated
2-Aminofluorene 10 306 3098
20 390 3546
4-Aminobiphenyl 10 9 195
20 2 409
aTo allow comparisons of equivalent activating cells, rever-
tants were corrected to 100% viability and 6 x 106 cells per
plate. Experiments required 4 x 106 bladder cells and 6 x 106
hepatocytes for these chemicals for optimum response.
Spontaneous revertants subtracted; a average was 23.
mucosa observed low levels of N-oxidization of aro-
matic amines. More recently, Poupko et al. (10) dem-
onstrated 4ABP N-hydroxylase activity in bovine
bladder mucosal microsomes. Preliminary studies
we have conducted suggest that dog bladder epithe-
lial cells are less active than bovine bladder cells in
activating aromatic amines, which is in agreement
with the separate findings of Brill (33) and Poupko
et al. (10). Such findings may indicate species differ-
ences in the metabolic capabilities and therefore re-
sultant roles of the bladder epithelium in the activa-
tion of bladder carcinogens.
We found it interesting that bovine hepatocytes
were less active on a per cell basis than bovine blad-
der cells in activating AF and 4ABP to mutagens. It
should be stressed that mutagen production and re-
lease from the two cell types are being measured,
and the data do not necessarily imply that total me-
tabolism is following the same patterns. Indeed, dif-
ferent metabolic pathways may predominate in the
151OGLESBYETAL.
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FIGURE 3. Comparison of activation of AF and 4ABP by intact bladder cells and cell fractions. 4 x 106 cells or S-9 equivalent in
900 pL was added per plate.
liver, where detoxification and conjugation may be
major pathways with less release of mutagenic in-
termediates. On the other hand, the bladder may
have less conjugation potential and therefore re-
lease reactive intermediates more readily. How-
ever, in agreement with our mutagenesis results,
Poupko et al. (10), usingN-hydroxylation of 4ABP as
a measure of metabolism, observed substantial
activity in bovine bladder microsomes with un-
detectable activity in bovine liver which further
suggests a role for the bovine bladder in activating
aromatic amines. Evidence that the bladder is not
involved in aromatic amine activation comes mostly
from carcinogen instillation and pellet implantation
studies (34). In dogs and rats, such treatment with
parent amines did not result in tumor formation,
while treatment of dogs with the N-hydroxynaph-
thylamine did induce tumors (34-36). However, im-
plantation with other carcinogens such as dibenzo-
carbazole (37), 3-methylcholanthrene and certain azo
compounds have caused bladder tumors (34). Again,
species variation in response may account for some
of these differences and general conclusions about
the lack of involvement of bladder epithelium acti-
vation may be premature. Furthermore, while the
liver may be an initial site for aromatic amine me-
tabolism, the actual time and concentration the
chemical is in contact with the liver could be vari-
able, whereas the bladder could encounter concen-
trated levels of the chemical and/or metabolites for
prolonged times. Also, there is a large difference in
cell numbers between the two tissues and even
with less activating capability per cell, total mass
would probably allow the liver to metabolize
greater levels of chemical. How such factors could
influence the relative importance of liver and
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bladder carcinogen activation in the initiation of
bladder cancer is unknown.
The need for cautious choice of the target organ-
ism is also indicated in the present studies. With
bladder cell activation, V79 cells detected DMBA,
AF and with a lower sensitivity, 4ABP as mutagen-
ic. Conversely, S. typhimurium with bladder cell ac-
tivation was not reverted by DMBA, but detected
AF and 4ABP as mutagenic with significant in-
creases over background. At present the causes of
the different sensitivities of the target organisms
can only be speculated about, but the data indicate
the need for using multiple endpoints when assess-
ing activation potential.
Bovine bladder S-9 was also capable of activating
aromatic amines. In fact, the equivalent bladder S-9
was more effective in activating AF and 4ABP to
mutagens for S. typhimur?ium than intact bladder
cells (Fig. 3). This increased activity with S-9 could
be due to trapping of active intermediates in intact
cells, loss of conjugating enzymes upon cell disrup-
tion, closer proximity of S-9 enzymes to the target
organism and/or other causes. However, it should
be emphasized that the chemical class as well as tar-
get organism can determine which activation
system is optimal as nitrosamines and hydrocarbons
are sensitively detected with intact cellular ac-
tivation and V79 cells as the target (25). Fur-
thermore, intact cells are advantageous, since
enzyme systems other than those requiring
NADPH may be contributing to metabolic activa-
tion of some bladder carcinogens. Prostaglandin
synthetase is an example of such an enzyme system
which may be involved in carcinogen activation in
the bladder (38).
In summary, the present results indicate the
presence of enyzmes in bovine bladder cells which
activate aromatic amines to mutagens, and suggest
a possible role of the bladder epithelium in car-
cinogen activation.
We are grateful to Faye Gregory for exemplary typing
skills and Erica Perry for technical assistance. This work was
supported in part by a National Research Council-Environ-
mental Protection Agency postdoctoral award to Dr. Hix-
Baker.
REFERENCES
1. Veys, C. A. Two epidemiological inquiries into the inci-
dence of bladder tumors in industrial workers. J. Natl.
Cancer Inst. 43: 219-226 (1969)
2. Case, R. A. M., and Hosker, M. E. Tumour of the urinary
bladder as an occupational disease in the rubber industry
in England and Wales. Brit. J. Prevent. Soc. Med. 8: 39-50
(1954).
3. Case, R. A. M., Hosker, M. E. McDonald, D. B., and
Pearson, J. T. Tumours of the urinary bladder in work-
men engaged in the manufacture and use of certain dye-
stuff intermediates in the British chemical industry. Part
I. The role of aniline, benzidine, alpha-napthylamine and
beta-napthylamine. Brit. J. Ind. Med. 11: 75-104 (1954).
4. Case, R. A. M., and Pearson, J. T. Tumours of the urinary
bladder in workmen engaged in the manufacture and use
of certain dyestuff intermediates in the British chemical
industry. Part II. Further considerations of the role of
aniline and of the manufacture of auramine and magenta
(fucshin) as possible causative agents. Brit. J. Ind. Med.
11: 213-216 (1954).
5. Falk, K., Sorsa, M., and Vainio, H. Mutagenicity of urine
of workers in rubber industry. Mutat. Res. 79: 45-52
(1980).
6. Miller, J. A., Cramer, J. W., and Miller, E. C. The N- and
ring hydroxylation of 2-acetylaminofluorene during carci-
nogenesis in the rat. Cancer Res. 20: 950-962 (1980).
7. Boyland, E., and Manson, C. The biochemistry of aromatic
amines. Biochem. J. 101: 84-100 (1966).
8. Kadlubar, F. F., Miller, J. A., and Miller, E. C. Hepatic mi-
crosomal N-glucuronidation and nucleic acid binding of N-
hydroxy arylamines in relation to urinary bladder carcino-
genesis. Cancer Res. 37: 805-814 (1977).
9. Poupko, J. M., Hearn, W. L., and Radomski, J. L. N-
Glucuronidation of N-hydroxy aromatic amines: A mech-
anism for their transport and bladder-specific carcinoge-
nicity. Toxicol. Appl. Pharmacol. 50: 479-484 (1979).
10. Poupko, J. M., Radomski, J. L. and Hearn, W. L. Bovine
bladder mucosa microsomal cytochrome P-450 and 4-ami-
nobiphenyl N-hydroxylase activity. Cancer Res. 41: 1306-
1310 (1981).
11. Malick, L. E., and Langenbach, R. Urinary bladder epithe-
lial cell-mediated mutagenesis studies with chemical
carcinogens. J. Cell Biol. 83, 112a (1979).
12. Langenbach, R., Malick, L., and Nesnow, S. Bladder cell-
mediated mutagenesis. J. Natl. Cancer Inst. 66: 913-917
(1981).
13. Autrup, H., Grafstrom, R. C., Christensen, B., and Kieler,
J. Metabolism of chemical carcinogens by cultured human
and rat bladder epithelial cells. Carcinogenesis 2: 763-768
(1981).
14. Moore, B. P., Hicks, R. M., Knowles, M. A., and Redgrave,
S. Metabolism and binding of benzo(a)pyrene and 2-acetyl-
aminofluorene by short-term organ cultures of human and
rat bladder. Cancer Res. 42: 642-648 (1982).
15. Oglesby, L. A., Flammang, T. J., Tullis, D. L., and Kadlu-
bar, F. F. Rapid absorption, distribution, and excretion of
carcinogenic N-hydroxyarylamines after direct urethral
instillation into the rat urinary bladder. Carcinogenesis 2:
15-20 (1981).
16. Goldblatt, M. W., Henson, A. F., and Somerville, A. R.
Metabolism of bladder carcinogens. 3. The metabolic path
of 2-[8-'4C]naphthylamine in several animal species. Bio-
chem. J. 77: 511-516 (1960).
17. Uehleke, H. Resorption von Arylamines aus der Harn-
blase. Naunyn-Schmiedeberg's Arch. Pharmacol. 261: 218-
224 (1968).
18. Rowland, R. G., and Oyasu, R. Permeability of heterotopic
and homotopic rat urinary bladders to water, sodium and
a carcinogenic aromatic amine. Urol. Res. 8: 101-106
(1980).
19. Langenbach, R., Freed, H. J., and Huberman, E. Liver
cell-mediated mutagenesis of mammalian cells by liver
carcinogens. Proc. Natl. Acad. Sci. (U.S.) 75: 2864-2867
(1978).
20. Langenbach, R., Freed, H. J., Raveh, D., and Huberman,
E. Cell specificity in metabolic activation of aflatoxin B,
and benzo[a]pyrene to mutagens for mammalian cells. Na-
ture 276: 277-280 (1978).154 OBLESBYETAL.
21. Tompa, A., and Langenbach, R. Culture of adult rat lung
cells: benzo[a]pyrene metabolism and mutagenesis. In
Vitro 15: 569-478 (1979).
22. Langenbach, R., Nesnow, S., Tompa, A. Gingell, R., and
Kuszynski, C. Lung and liver cell-mediated mutagenesis
systems: specificities in the activation of chemical carcino-
gens. Carcinogenesis 2: 851-858 (1981).
23. Langenbach, R., Nesnow, S., Malick, L., Gingell, R., Tom-
pa, A., Kuszynski, C., Leavitt, S., Sasseville, K., Cudak,
C., and Montgomery, L. Organ specific activation of
carcinogenic polynuclear aromatic hydrocarbons in cell
cultures. In: Polynuclear Aromatic Hydrocarbons (M.
Cooke and A. J. Dennis, Eds.), Fifth International Sympo-
sium, 1981, Columbus, Ohio, p. 75-84.
24. Langenbach, R., and Nesnow, S. Cell-mediated mutagene-
sis: an approach to studying organ specificity of chemical
carcinogens. In: Organ and Species Specificity of Chemical
Carcinogens (R. Langenbach, S. Nesnow, and J. Rice,
Eds.), Plenum Press, New York, 1982.
25. Langenbach, R., and Oglesby, L. Application of cellular
activation systems in genetic toxicology assays. In: Chem-
ical Mutagens: Principles and Methods for Their Detec-
tion (F. J. de Serres, Ed.), Plenum Press, New York Vol.
8, in press.
26. Huberman, E., and Sachs, L. Cell-mediated mutagenesis
of mammalian cells with chemical carcinogens. Int. J. Can-
cer 13: 326-333 (1974).
27. Oglesby, L., Hix-Baker, C., Sieg, M., Snow, L., MacNair,
P., and Langenbach, R., Bladder urothelial cell activation
of aromatic amines to mutagens. In preparation.
28. Hix-Baker, C., Oglesby, L., MacNair, P., Sieg, M., Snow,
L., and Langenbach, R. Bovine bladder and liver cell and
cell homogenate-mediated mutagenesis of Salmonella
typhimurium with aromatic amines. In preparation.
29. Ames, B. N., McCann, J., and Yamasaki, E. Methods for
detecting carcinogens and mutagens with the Salmonella/-
mammalian-microsome mutagenicity test. Mutat. Res. 31:
347-363 (1975).
30. Lowry, O., Rosebrough, N., Farr, A., and Randall, R. Pro-
tein measurements with folin phenol reagent. J. Biol.
Chem. 193: 265-275 (1951).
31. Fry, J. R., Jones, C. A., Wiebkin, P., Belteman, P., and
Bridges, J. W. The enzymatic isolation of adult rat hepa-
tocytes in a functional and viable state. Anal. Biochem. 71:
341-350 (1976).
32. Uehleke, H. N-Hydroxylation of arylamines by bladder
mucosa. Life Sci. 5: 1489-1494 (1966).
33. Brill, E. The role of dog bladder mucosa in the N-
oxidation of arylamines. Res. Commun. Chem. Pathol.
Pharmacol. 16: 73-84 (1977).
34. Clayson, D. B., and Cooper, E. H. Cancer of the urinary
tract. In: Advances in Cancer Research, Vol. 13, (G. Klein,
S. Weinhouse, and A. Haddow, Eds.), Academic Press,
New York, 1970, pp. 271-381.
35. Radomski, J. L., Brill, E., Deichman, W. B., and Glass,
E. M. Carcinogenicity testing of N-hydroxy and other
oxidation and decomposition products of 1- and 2-naph-
thylamine. Cancer Res. 13: 1461-1467 (1971).
36. Radomski, J. L., and Brill, E. Bladder cancer induction by
aromatic amines: role of N-hydroxy metabolites. Science
167: 992-993 (1970).
37. Bonser, G. M., Crabbe, J. C. S., Jull, J. W., and Pyrah,
L. N. Inductions of epithelium neoplasm in the urinary
bladder by intravesical injection of a chemical carcinogen.
J. Pathol. Bacteriol. 68: 561-564 (1954).
38. Zenser, T. V., Armbrecht, M. B., and Davis, B. B. Metabo-
lism of N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide by
prostaglandin endoperoxide synthetase. Cancer Res. 40:
114-118 (1980).